In an ongoing effort to promote the usage of FDA-approved drugs, Cindy Ippoliti, Pharm.D., NYP/Weill Cornell, has authored a Drug Safety White Paper:The Hazards of Unapproved Drugs and Importance of Utilizing Approved Drugs.
Cindy was assisted by Christan Thomas, Pharm.D. and Frank Cirrone, Pharm.D. from NYP/Weill Cornell.
Each year dozens of drugs that are proven to be safe and effective are approved by the US Food and Drug Administration (FDA). However, many unapproved products remain on the market, “grandfathered” by older regulations.
The use of unapproved drugs can not only lead to legal action, but also poses a significant public health concern — particularly for those agents that have been previously “grandfathered” into the system. Once an FDA-approved formulation becomes available, early adoption is key for financial peace of mind, patient safety, and quality healthcare delivery. Continued use of non-approved drugs when a safe, FDA-approved product is available is not in the public interest and can lead to legal action.” #ResidencyProgramDirector #PharmacyPracticeManagers #PharmacyStudents #DirectorofPharmacy #PharmacyBuyers #Resident
The Drug Safety White Paper is available at: http://www.expectad.com/wp.pdf